From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Saline, Not Albumin, for Patients with Head Injury

Albumin use is associated with a significantly higher death rate.

The Saline versus Albumin Fluid Evaluation (SAFE) study was a randomized, double-blind comparison of saline and albumin in a heterogeneous population of intensive care unit patients. The study showed no difference in outcomes between treatment groups but suggested an increased death rate in patients with traumatic brain injury who received albumin. However, the trial was not directed specifically toward patients with head injury.

Researchers reevaluated data from the SAFE study for patients with traumatic brain injury (SAFE-TBI study), using specific measures of injury severity, including Glasgow Coma Scale (GCS) score and intracranial pressure. In addition, whereas the original study measured outcomes up to 28 weeks after admission, this study measured outcomes (death and disability) at 24 months.

Of 460 patients with traumatic brain injury, 69% had severe injury (GCS score of 3–8). At 24 months, 33.2% of the albumin group had died, as compared to 20.4% of the saline group. This difference was due to a marked disparity in survival in the subgroup of patients with severe head injury; mortality rates were 41.8% in those treated with albumin and 22.2% in those treated with saline (relative risk, 1.88). Among survivors, neurologic outcomes were similar in the two treatment groups.

Comment: The albumin versus saline debate has been going on for a long time, and albumin has never been shown to be better, despite its much higher cost. In this study, albumin was associated with significantly worse outcomes. For patients with head injury, albumin should be allowed to gather dust in the pharmacy. The money would be better spent elsewhere.

J. Stephen Bohan, MD, MS, FACP, FACEP

Published in Journal Watch Emergency Medicine September 28, 2007

Citation(s):

The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007 Aug 30; 357:874.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.